UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
11.72
+0.27 (2.36%)
Nov 21, 2024, 12:00 PM EST - Market open
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $494.58 million as of November 21, 2024. Its market cap has increased by 38.04% in one year.
Market Cap
494.58M
Enterprise Value
351.71M
1-Year Change
38.04%
Ranking
Category
Stock Price
$11.72
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $167.38M to $494.58M, an increase of 195.49%. That is a compound annual growth rate of 15.42%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-mAbs Therapeutics | 475.66M |
| MeiraGTx Holdings | 473.61M |
| Zevra Therapeutics | 472.38M |
| Perspective Therapeutics | 472.10M |
| GRAIL | 471.75M |
| Treace Medical Concepts | 463.49M |
| Arcturus Therapeutics Holdings | 461.84M |
| OmniAb | 461.66M |